Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: A substudy of the ECOST trial

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 7, 2014, Pages 763-770

  Guédon Moreau, Laurence ^a   Kouakam, Claude ^a   Klug, Didier ^a   Marquié, Christelle ^a   Brigadeau, François ^a   Boulé, Stéphane ^a   Blangy, Hugues ^b   Lacroix, Dominique ^a   Clémenty, Jacques ^c   Sadoul, Nicolas ^b   Kacet, Salem ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CHU NANCY BRABOIS   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

implantable cardioverter defibrillator; inappropriate shock; lead dysfunction; oversensing; remote monitoring; telemedicine; supraventricular tachyarrhythmias

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS;

ADULT; AMBULATORY CARE; ARTICLE; ATRIOVENTRICULAR CONDUCTION; AUTOMATION; BRUGADA SYNDROME; CARDIOVERSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NOISE; PREVALENCE; PRIORITY JOURNAL; R WAVE; RADIOFREQUENCY ABLATION; REMOTE SENSING; SHOCK WAVE; SUPRAVENTRICULAR TACHYCARDIA; T WAVE; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; DEVICES; EARLY DIAGNOSIS; ELECTRIC INJURIES; FRANCE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TELEMEDICINE; TIME FACTOR; TREATMENT OUTCOME;

AGED; AMBULATORY CARE; DEFIBRILLATORS, IMPLANTABLE; EARLY DIAGNOSIS; ELECTRIC COUNTERSHOCK; ELECTRIC INJURIES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REMOTE SENSING TECHNOLOGY; RISK FACTORS; TELEMEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904459228     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12405     Document Type: Article

References (14)

1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW,; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons: ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: 2820-2840.
2. Germano JJ, Reynolds M, Essebag V, Josephson ME,: Frequency and causes of implantable cardioverter-defibrillator therapies: Is device therapy proarrhythmic? Am J Cardiol 2006; 97: 1255-1261.
3. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ,; MADIT II Investigators: Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365.
4. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W,; the MADIT-RIT Trial Investigators: Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367: 2275-2283.
5. Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JBM, Hersi A, Gulaj M, Wijfels M, Santi E, Manotta L, Arenal A,: Effect of long-detection interval vs standard-detection interval for implantable cardioverter- defibrillators on antitachycardia pacing and shock delivery. The ADVANCE III Randomized Clinical Trial. JAMA 2013; 309: 1903-1911.
6. Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C,: Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: Results from the PROVIDE study. J Cardiovasc Electrophysiol 2014; 25: 52-59.
7. Guédon-Moreau L, Lacroix D, Sadoul N, Clémenty J, Kouakam C, Hermida JS, Aliot E, Boursier M, Bizeau O, Kacet S,; for the ECOST trial Investigators: A randomized study of remote follow-up of implantable cardioverter defibrillators: Safety and efficacy report of the ECOST trial. Eur Heart J 2013; 34: 605-614.
8. Guédon-Moreau L, Chevalier P, Marquié C, Kouakam C, Klug D, Lacroix D, Brigadeau F, Kacet S,: Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J 2010; 31: 2246-2252.
9. Lazarus A,: Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: Analysis of a worldwide database. Pacing Clin Electrophysiol 2007; 30: S2-S12.
10. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C,; TRUST Investigators: Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial. Circulation 2010; 122: 325-332.
11. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ,: Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57: 556-562.
12. Powell BD, Saxon LA, Boehmer JP, Day JD, Roosevelt Gilliam III F, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL,: Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol 2013; 62: 1674-1679.
13. Kleemann T, Hochadel M, Strauss M, Skarlos A, Seidl K, Zahn R,: Comparison between atrial fibrillation-triggered Implantable Cardioverter-Defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: Different impact on prognosis in clinical practice. J Cardiovasc Electrophysiol 2012; 23: 735-740.
14. Mabo P, Defaye P, Sadoul N, Davy J-M, Deharo J-C, Kacet S, Bellissant E, Daubert J-C,: EVATEL: Remote follow-up of patients implanted with an ICD: The prospective randomized EVATEL study. ESC Congress report. Hot Line II-Frontiers in interventional and device treatments. http://www.escardio.org/congresses/esc- 2011/congress-reports/.Pages/707-1-EVATEL.aspx (last accessed February 10, 2014).